PMA device
Bioenterics Lap-Band Adjustable Gastric Banding System
Medtimo, Inc. · Implant, Intragastric For Morbid Obesity (LTI, Class III) · First FDA decision May 24, 2002, newest Dec 5, 2003Obesity
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
0
Naming "Bioenterics Lap-Band Adjustable"
MAUDE reports
0
Brand "Bioenterics Lap-Band Adjustable", since 2015
PubMed studies
0
Mentioning "Bioenterics Lap-Band Adjustable"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Bioenterics Lap-Band Adjustable Gastric Banding System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- BIOENTERICS LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEMPMA supplement
P000008-S006 · Decided Dec 5, 2003 · 183 days after receipt · Normal 180 Day Track
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
- BIOENTERICS LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEMPMA supplement
P000008-S005 · Decided Jan 8, 2003 · 48 days after receipt · Normal 180 Day Track
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
- BIOENTERICS LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEMPMA supplement
P000008-S004 · Decided Sep 10, 2002 · 180 days after receipt · Normal 180 Day Track
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Bariatric Surgery for the Treatment of Morbid Obesity - Facility Certification RequirementNational analysisReview closedCAG-00250R3Updated Sep 16, 2026
- Bariatric Surgery for the Treatment of Morbid ObesityNational analysisReview closedCAG-00250R2Updated Sep 16, 2026
- Bariatric Surgery for the Treatment of Morbid ObesityNational analysisReview closedCAG-00250RUpdated Sep 16, 2026
- Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid ObesityNational determinationOn the books100.1Updated Apr 9, 2025
- Bariatric Surgical Management of Morbid ObesityLocal determinationIn effectL35022Novitas Solutions, Inc.Updated May 7, 2021
- Surgical Management of Morbid ObesityLocal determinationIn effectL33411First Coast Service Options, Inc.Updated Oct 2, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Bioenterics Lap-Band Adjustable", any status and sponsor, newest update first.
No registered device study names "Bioenterics Lap-Band Adjustable".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Bioenterics Lap-Band Adjustable", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code LTI
5,233 reports: 2,779 malfunction, 2,372 injury, 70 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2743-2018 · Started Nov 22, 2017
Reason given: Component of the Lap-Band system was missing from the package
Cause as FDA categorized it: Under Investigation by firm · Device type: Implant, Intragastric For Morbid Obesity (LTI)
Z-2123-2011 · Started Mar 21, 2011 · Posted by FDA May 2, 2011
Reason given: The recall was initiated because Allergan has determined that a number of Access Port Needle pouches from one specific lot number may have small gaps in a pouch seal. Consequently the product may no longer be sterile.
Cause as FDA categorized it: Pending · Device type: Implant, Intragastric For Morbid Obesity (LTI)
Z-0418-2011 · Started Sep 16, 2010 · Posted by FDA Nov 18, 2010
Reason given: In a LAP-BAND System adjustment, failure to inject the needle perpendicular to the access port septum, as described in Directions for Use, may lead to port damage, resulting in subsequent port leakage. Leakage results in deflation of the LAP-BAND to its widest, open position requiring a procedure to replace the port....
Cause as FDA categorized it: Pending · Device type: Implant, Intragastric For Morbid Obesity (LTI)
Published research
The most relevant PubMed records for "Bioenterics Lap-Band Adjustable"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LTI.
- Lap-Band Adjustable Gastric Banding SystemMedtimo, Inc. · PMA 2023
- Obalon Balloon SystemMedtimo, Inc. · PMA 2022
- Orbera Intragastric BalloonBoston Scientific Corporation · PMA 2026
- ReShape Integrated Dual Balloon SystemBoston Scientific Corporation · PMA 2018
- Allurion Gastric Balloon SystemAllurion Technologies, Inc. · PMA 2026
- Spatz3 Adjustable Balloon SystemSpatz Fgia, Inc. · PMA 2023
- Ethicon Endo-Surgery Curved Adjustable Gastric with Sutureless Port and ApplierObtech Medical GmbH · PMA 2016
- Realize Adjustable Gastric BandObtech Medical GmbH · PMA 2011
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.